Skip Ribbon Commands
Skip to main content

Biotech Buzz


Quick Launch

Biotech Buzz > Posts > May 2016 - Biotech Buzz
June 09
May 2016 - Biotech Buzz

Members of the Biotechnology Committee – You can view the latest issue of the Biotech Buzz below and access detailed information by clicking the names and other hyperlinks.  The more links below download the given article.  Click here to download the entire Biotech Buzz as a pdf file.


If you want to be active in the committee, click here  and indicate your interests, ideas, and contact information in your email.  Alternatively, contact the Leader and Sub-Chair(s) of the particular subcommittee of interest.



May 2016


Chair’s NotesDebora Plehn-Dujowich: … more

30th WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC)


I am currently attending the 30th IGC in Geneva, Switzerland which will take place from May 30-June 3, 2016. During the plenary session of the IGC, I read a statement based on an AIPLA Board Resolution on Genetic Resources more

To read more about the 30th IGC click here.


Buzz Editor – Debora Plehn-Dujowich and Vicki Norton

Microsite Master John Marquardt


Vice ChairVicki Norton: A quick thanks to our Spring Meeting panelists, Marian Flattery from Dupont Pioneer, Kan Wang from Iowa State University, Debora Plehn Dujowich from Prismatic Law Group and Kate Hibbard from Greene Espel, for their excellent discussion of patent eligibility, regulatory, genetic resource and export control considerations for bio-engineered plants, and to Alice Martin, Mark Pidkowich and Katharine Koenig who assisted with the presentation.more




Services Leader’s NotesCarla Mouta

USPTO Relations Suzannah Sundby and Ron Kamis

Ron Kamis reports on the BCP meeting of April 26 and the Patent Quality Meeting more

Webinars Carla Mouta

Carla Mouta reports on there will be a CLE webinar on July 27 regarding Building a Global Portfolio: Double Patenting and Unity of Invention Pitfalls in US, Europe, and Asia.   more



Issues Leader’s NotesNicholas Landau

Biotech Litigation – Bryan Diner, Patrice Jean and Laura Smalley

Laura Smalley reports on Amgen Sues Sandoz for Patent Infringement Over Pegfilgrastim Biosimilar more

Diagnostics & Gene Patenting – George Yu and John Peterson

Laura Arneson reports on the new USPTO Section 101 Biotech Examples more

PTAB Actions – Herb Hart and Malaika Tyson

Taras A. Gracey & Robert F. Kappers report on PTAB Grants Request for Rehearing and Institutes Inter Partes Review of Onglyza® (Saxagliptin) Patents more



Community Leader’s NotesRyan Chirnomas and Alice Martin

International David Read and Trevor Davies

Yoon Suk Shin of Lee International reports on Korean Case Law Update: Recent Korean Supreme Court Decision on Inventive Step of Medical Use Invention more

Duncan Ribbons and Maeve Lynch of Redd Solicitors report on a recent UK decision in which a declaration was sought to ultimately avoid infringement of a yet to be granted patent application more



Feel free to send comments and recommendations to a Committee Leader using the Leader’s email icon or send an email the Chair, Vice Chair, and all Leaders by clicking the envelope: .

The Fine Print: These materials are public information and have been prepared solely for educational and entertainment purposes to contribute to the understanding of intellectual property law. These materials reflect only the personal views of the authors and are not a source of legal advice. It is understood that each case is fact specific, and that the appropriate solution in any case will vary. Therefore, these materials may or may not be relevant to any particular situation. Thus, the authors and their organizations cannot be bound either philosophically or as representatives of their various present and future clients to the comments expressed in these materials. The presentation of these materials does not establish any form of attorney-client relationship with the authors or their organizations. While every attempt was made to ensure that these materials are accurate, errors or omissions may be contained therein, for which any liability is disclaimed.



There are no comments for this post.